Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

20202,162 citationsJournal Articlegreen Open Access

Authors

Muthiah Vaduganathan · Brigham and Women's Hospital

Orly Vardeny · University of Minnesota

Thomas Michel · Brigham and Women's Hospital

John J.V. McMurray · British Heart Foundation

Marc A. Pfeffer · Brigham and Women's Hospital

Scott D. Solomon · Brigham and Women's Hospital

Abstract

RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hy...

Topics & Keywords

Hormonal Regulation and Hypertension COVID-19 Clinical Research Studies Renin-Angiotensin System Studies

Publication Details

Published in: New England Journal of Medicine

Volume 382, Issue 17, pp. 1653-1659

DOI: 10.1056/nejmsr2005760

Field-Weighted Citation Impact: 291.00

Command Palette

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

Authors

Abstract

Topics & Keywords

Publication Details